|
ZNF706 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.82470002943569E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.50440000141239E-08 |
| Normal-vs-Stage2 |
2.74600000005343E-06 |
| Normal-vs-Stage3 |
1.01910000438465E-08 |
| Normal-vs-Stage4 |
2.17219999765206E-08 |
| Stage1-vs-Stage2 |
1.524030E-01 |
| Stage1-vs-Stage3 |
1.866200E-01 |
| Stage1-vs-Stage4 |
3.989600E-01 |
| Stage2-vs-Stage3 |
5.295600E-01 |
| Stage2-vs-Stage4 |
3.640600E-01 |
| Stage3-vs-Stage4 |
6.681000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.82289796777513E-11 |
| Normal-vs-AfricanAmerican |
1.575300E-03 |
| Normal-vs-Asian |
3.362500E-04 |
| Caucasian-vs-AfricanAmerican |
2.424400E-01 |
| Caucasian-vs-Asian |
5.711600E-02 |
| AfricanAmerican-vs-Asian |
8.152600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36849998000343E-09 |
| Normal-vs-Female |
9.78949998842182E-09 |
| Male-vs-Female |
1.624210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.82669999968266E-07 |
| Normal-vs-Age(41-60Yrs) |
8.28140001019051E-09 |
| Normal-vs-Age(61-80Yrs) |
2.84180012855018E-10 |
| Normal-vs-Age(81-100Yrs) |
1.503170E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.696200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.518400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.653200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.849230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.571800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.437200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.303000E-01 |
| Classical-VS-Follicular |
1.332450E-02 |
| Classical-VS-Other |
7.257000E-01 |
| Classical-VS-Normal |
2.7050000017681E-09 |
| Tall-VS-Follicular |
1.428790E-01 |
| Tall-VS-Other |
7.779800E-01 |
| Tall-VS-Normal |
2.618900E-03 |
| Follicular-VS-Other |
5.839000E-01 |
| Follicular-VS-Normal |
3.67010000168477E-09 |
| Other-VS-Normal |
1.144490E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.99059699016402E-11 |
| Normal-vs-N1 |
1.40599999998159E-06 |
| N0-vs-N1 |
2.516000E-01 |
|
|
